Draw on Our Experience in Gene Therapy

Featured Product Highlight

The VirusExpress™ Lentiviral Production Platform provides a scalable and high-yield lentiviral vector production platform. Transient transfection of a suspension-adapted HEK 293T derived production cells in chemically defined medium (Figure 1) shows proven performance at clinically relevant scale while utilizing a simplified process. Optimal viral titers have been demonstrated in 3 production runs at a 40 L working volume (Figure 2). The VirusExpress Lentiviral Production Platform features not only cells and chemically defined medium but also proven process performance to help you speed your gene therapy to patients.

Figure 1. Cell viability (dashed lined) and cell growth data (solid lines)

Figure 2. Each run exceeded a target functional titer of 1 x 10⁷ TU/mL
and demonstrated successful scale-up to 40 L

Download the VirusExpress™ Lentiviral Production Platform White Paper

Process Development and scale-up for Transient Transfection-Based Lentivirus Production in suspension White Paper.

Ordering Information

To place an order, please click on the button below:

For more Information

For information regarding the cell line, medium, and licenses available, please click on the button below: